NSE · LT.NS
Larsen & Toubro Limited
₹3,871.70+₹34.60 (+0.9%)
Larsen & Toubro Limited’s quoted price sits in the upper half of its reported 52-week range, 12.8% below the high.
Loading market information…
BSE · CHOKSILA.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 09:34 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Choksi Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Choksi Laboratories Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical, and construction material analysis. The company's instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. It also offers environment management, laboratory set-up and management, waste water management, and air pollution monitoring services. In addition, the company provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, and auditing. Further, it offers assaying and hallmarking services for gold and silver. The company serves the pharmaceuticals, consumer products, and engineering sectors. Choksi Laboratories Limited was founded in 1982 and is based in Indore, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹3,871.70+₹34.60 (+0.9%)
Larsen & Toubro Limited’s quoted price sits in the upper half of its reported 52-week range, 12.8% below the high.
₹1,907.20-₹4.50 (-0.24%)
Dr. Lal PathLabs Limited’s quoted price sits in the upper half of its reported 52-week range, 6.45% below the high.
₹485.60-₹34.20 (-6.58%)
Vimta Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 33.93% below the high.
₹133.80+₹6.35 (+4.98%)
Aspira Pathlab & Diagnostics Limited’s quoted price sits in the upper half of its reported 52-week range, 10.79% below the high.
₹137.00-₹0.50 (-0.36%)
Techknowgreen Solutions Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.97% below the high.
₹11.82-₹0.04 (-0.34%)
Samsrita Labs Ltd.’s quoted price sits in the lower half of its reported 52-week range, 53.23% below the high.
₹13.00₹0.00 (0.0%)
Nidan Laboratories & Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.79% below the high.
₹6.95₹0.00 (0.0%)
Dr. Lalchandani Labs Ltd.’s quoted price sits in the lower half of its reported 52-week range, 70.66% below the high.
